No Data
No Data
Press Release: Trillium Securityholders Approve Acquisition by Pfizer
Trillium Securityholders Approve Acquisition by Pfizer CAMBRIDGE, Mass., Oct. 26, 2021 (GLOBE NEWSWIRE) -- Trillium Therapeutics Inc. ("Trillium" or the "Company") (NASDAQ/TSX: TRIL), a clinica
Morning News Call - Canada, October 26
To access a PDF version of this newsletter, please click here You can read Morning News Call Canada via TOPNEWS Canada page.If you would like to receive this newsletter through your email, please regi
BRIEF-Trillium Therapeutics Inc Says Pfizer Voluntarily Withdrew Its Hart-Scott-Rodino Act Filing, And Expects To Re-File Such Form On Or About October 14
Oct 13 (Reuters) - Trillium Therapeutics Inc TRIL.TO :* TRILLIUM THERAPEUTICS - ON OCT 12, 2021, PFIZER VOLUNTARILY WITHDREW ITS HART-SCOTT-RODINO ACT FILING, AND EXPECTS TO RE-FILE SUCH FORM ON OR A
SHAREHOLDER ALERT: WeissLaw LLP Reminds DSPG, ADTN, TRIL, and VNE Shareholders About Its Ongoing Investigations
NEW YORK, Sept. 21, 2021 /PRNewswire/ -- If you own shares in any of the companies listed above and would like to discuss our investigations or have any questions concerning this notice or your righ
INVESTIGATION: Halper Sadeh LLP Investigates INOV, SAFM, LMRK, AVCO, TRIL, XENT; Shareholders are Encouraged to Contact the Firm
NEW YORK, Sept. 9, 2021 /PRNewswire/ -- Halper Sadeh LLP, a global investor rights law firm, announces it is investigating the following companies: Inovalon Holdings, Inc. (NASDAQ: INOV) concerning